Market Overview

UPDATE: Morgan Stanley Initiates HCA Holdings at Overweight on Potential Reform Benefits

Share:
Related HCA
Sell-Side Takes Community Health's Vital Signs After Sickly Q2 Preview Release
Earnings Scheduled For July 25, 2017
Desperate GOP Clears Key Senate Health Care Hurdle (Investor's Business Daily)

Morgan Stanley initiated HCA Holdings (NYSE: HCA) with an Overweight rating and a $47.00 price target.

Morgan Stanley noted, "Healthcare reform will support double-digit earnings growth for HCA from 2014 through 2016. We forecast EBITDA growth of 11.4% in 2014, 11.8% in 2015, and 10.6% in 2016 driven by reform, which contributes 5.6% to EBITDA in 2014, 7.8% in 2015, and 8.1% in 2016. Our model factors in: 1) uninsured adoption by state, allocating lives between exchanges and Medicaid, 2) pricing and enrollment for the exchanges, 3) pricing for Medicare, commercial and Medicaid, and 4) exposure to various regulated and proposed cuts including disproportionate share (DSH)."

HCA Holdings closed at $37.22 on Friday.

Latest Ratings for HCA

DateFirmActionFromTo
Jul 2017Morgan StanleyMaintainsEqual-Weight
Jul 2017CitigroupMaintainsNeutral
Jul 2017Bank of AmericaDowngradesBuyNeutral

View More Analyst Ratings for HCA
View the Latest Analyst Ratings

Posted-In: Morgan StanleyAnalyst Color Initiation Analyst Ratings

 

Related Articles (HCA)

View Comments and Join the Discussion!